# Hil-Invent

> Hil-Invent is a VC fund backing Health Care, Medical and Wellness. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Nov 2025
- Lead investor: 20%
- Last updated: Aug 2026

Hil-Invent is a VC fund focused on Health Care and Medical. Hil-Invent operates as an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 40% |
| Medical | 1 | 20% |
| Wellness | 1 | 20% |
| Therapeutics | 1 | 20% |
| Medical Device | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 20% |
| Series B | 1 | 20% |
| Series C | 1 | 20% |
| Funding Round | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 1 | 20% |
| Germany | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Captain T Cell | Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates. | $23.2M |  | Nov 17, 2025 |  |
| UroMems | UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. | $47.1M | Series C | Jun 25, 2024 |  |
| Captain T Cell | Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates. | $9.2M | Seed | May 22, 2024 |  |
| UroMems | UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. | $8.3M | Series B | Apr 06, 2021 |  |
| UroMems | UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. | $17.6M | Series B | May 20, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [Wellington Partners](https://shizune.co/investors/profile/wellington-partners) — VC Fund, 4 deals together
- [Arbevel](https://shizune.co/investors/profile/arbevel) — VC Fund, 3 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 3 deals together
- [b2venture](https://shizune.co/investors/profile/btovpartners) — VC Fund, 3 deals together
- [Supernova Invest](https://shizune.co/investors/profile/supernova-invest) — VC Fund, 3 deals together
- [Brandenburg Kapital](https://shizune.co/investors/profile/bfb-brandenburg-kapital-gmbh) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Wellness VC Funds in Germany](https://shizune.co/investors/wellness-vc-funds-germany)

## FAQ

### What does Hil-Invent invest in?

Hil-Invent invests primarily in Health Care, Medical and Wellness startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hil-Invent last invest?

The most recent investment recorded for Hil-Invent closed in Nov 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co